Progress in Neuro-Psychopharmacology & Biological Psychiatry
Schizophrenia and the gut–brain axisThe hyper-systemizing, assortative mating theory of autismBorderline personality–bipolar spectrum relationshipPsychomotor retardation in depression: biological underpinnings, measurement, and treatmentThe neurobiology of retinoic acid in affective disordersPharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic reviewInnate and adaptive immunity in the development of depression: An update on current knowledge and technological advancesTechnical advances in the characterization of the complexity of sleep and sleep disorders.Ghrelin and eating disordersCannabinoid modulation of noradrenergic circuits: implications for psychiatric disordersGeneral anesthetics and β-amyloid proteinThe neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injurySpice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsPerioperative delirium and its relationship to dementiaDevelopments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatmentDarwinian models of depression: a review of evolutionary accounts of mood and mood disordersIncreased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia -- Juntendo University Schizophrenia Projects (JUSP)Association study of polymorphisms in the mitochondrial aspartate/glutamate carrier SLC25A12 (aralar) gene with schizophreniaAMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakesTianeptine: potential influences on neuroplasticity and novel pharmacological effectsHas iprindole an alpha adrenergic activity?Effects of the dopamine agonist piribedil on prefrontal temporal cortical network function in normal aging as assessed by verbal fluencyThe role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatmentClinical overview on moclobemideA preliminary trial of ascorbic acid as supplemental therapy for autismNociceptin and the nociceptin receptor in learning and memoryPossible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in TaiwanAge-related cognitive decline in patients with mood disordersInvolvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming testRelative cataleptic potency of narcotic analgesics, including 3,6-dibutanoylmorphine and 6-monoacetylmorphineAmphetamine in rat brain after intraperitoneal injection of N-alkylated analoguesAntihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigationsPharmacokinetics and adverse effects of single doses of dothiepin in young and elderly subjectsCombination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depressionPutative neuroprotective agents in neuropsychiatric disordersAntidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic systemSequential serotonin and noradrenalin associated processes involved in postpartum bluesMolecular pharmacology of niaprazineAlcoholic organic brain disease: nosology and pathophysiologic mechanismsReduced expression of apolipoprotein E receptor type 2 in peripheral blood lymphocytes from patients with major depressive disorder
P1433
Q22251211-21466A42-BC2A-498C-8AE4-B1BBF17A4261Q22251212-B491F52A-C671-45C5-957B-0A212B728E28Q22251214-2E916D72-D5F2-4329-A24B-A32D58776927Q24629825-B57691B2-B033-46E1-80B3-66C3E54FBA21Q24654189-2BDE7494-5B0A-4CE6-9D92-A7AD13A874EAQ24657469-1D548131-77BF-48D0-BE3C-E2436243521AQ26775316-4437E94F-BD95-4B02-8161-B7179EC7E7DFQ26828885-2EC8D923-B62C-44DA-91AA-251F26306BF9Q26995199-4A97109C-13C3-4563-A5DD-6E0CC12710A6Q27001139-A88DBC5F-9283-469B-AAFF-9935A0FE5F54Q27010208-79CEA27F-4A9C-4727-A351-C3C4281E6F56Q27010520-125B9889-C702-4062-B313-D5764518DA18Q27010555-DFC3AEA6-3FA7-4D21-92CD-8516D765E886Q27013550-C52D20F1-499D-49D0-8848-F7F5AFF2D8B3Q28111919-C450E1F9-4BA1-4FE2-BA37-5295F0ECE364Q28237183-F0065436-594F-4B0A-93D3-A4BA70E7CAFCQ28238917-71500ED0-9F55-4FB1-81AF-5EF8537323C8Q28240415-CFFC9318-012C-4F12-B3BE-B2FD399C0E3FQ28242648-9010E951-9F7E-4687-8E13-7BE2AC283FADQ28247330-2810A04D-F392-44D9-8DCF-B09BA2BD37A3Q28248878-45339348-A2BC-4B8E-94A2-C6E132BD7806Q28254840-C064EC33-989E-4C9C-9035-D02D6C17B98EQ28256285-69003675-7D4A-4E09-938D-96003343B908Q28257192-015C69CA-241E-4CA1-B8F3-E7482BD12AB9Q28257201-E9C156D3-9D0D-42B7-A642-712690206ACBQ28257948-7E543070-1C9D-4F7F-A729-74349BD7958EQ28265920-BA9CA4DD-5F73-4AD1-B011-9D4C4633A31CQ28267007-DC107133-E95B-4518-BF15-DCE6D7AB5ADFQ28269474-C6D7B78B-AA97-4BFF-B790-857B329A8E14Q28270158-9345681A-C3E5-46EF-ABA4-068840451927Q28271919-9B825AAC-569D-477D-A87B-A21F00892AB6Q28276856-04FB65D7-C256-42C7-B537-587ABF9D0AC1Q28277735-1CF269E6-A255-424D-BC6B-5B2D4EF67C46Q28278009-82687071-D8AD-474C-B531-1914F62E9A60Q28279830-8E303BD7-EF60-4C31-A47C-8BEEFCDDCEFAQ28279909-2ADD8F53-8440-4A63-A5DF-B86C55053D6DQ28281378-0DA55DB2-FC8C-45DA-98FA-AD6CCACDF999Q28281827-93D52B60-AC17-43A3-A57F-15918B4DF82CQ28282557-2F8F6D87-9EB6-4B46-A196-2E7167444E12Q28283128-26D94906-9B6E-4D87-AE80-796F4DCA7C56
P1433
Progress in Neuro-Psychopharmacology & Biological Psychiatry
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Elsevier
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@ast
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@da
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@de
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@en
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@es
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@fi
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@fr
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@it
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@nb
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@nl
type
label
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@ast
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@da
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@de
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@en
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@es
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@fi
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@fr
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@it
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@nb
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@nl
prefLabel
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@ast
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@da
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@de
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@en
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@es
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@fi
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@fr
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@it
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@nb
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@nl
P243
P1058
P1159
P123
P1277
P1476
Progress in Neuro-Psychopharmacology & Biological Psychiatry
@en
P236
P243
P407
P571
1977-01-01T00:00:00Z
P5963
progress-in-neuro-psychopharmacology-and-biological-psychiatry